As the known biological function of CYP2C19 is related to estrogen catabolism, and as the studied deletion allele is expected to be a null allele, we further defined the status of the remaining CYP2C19 allele in relation to literature described metabolizer genotypes both in carriers with breast cancer and those remaining healthy. The gene discussed is CYP2C19; the disease is breast cancer.